Transplantation carries the risk of Kaposi sarcoma, which afflicts 1 out of 200 transplant recipients in the United States. An analysis of human post-transplant tumors indicates that the disease can originate from donor cells, highlighting the need for organ pre-screening.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barozzi, P. et al. Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat. Med. 9; advance online publication 7 April 2003; doi:10.1038/nm862.
Mendez, J.C. & Paya, C.V. Kaposi's sarcoma and transplantation. Herpes 7, 18–23 (2000).
Qunibi, W. et al. Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am. J. Med. 84, 225–232 (1988).
Parravicini, C. et al. Risk of Kaposi's sarcoma-associated herpesvirus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 90, 2826–2829 (1997).
Regamey, N. et al. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N. Engl. J. Med. 339, 1358–1363 (1998).
Yang, B.T. et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J. Exp. Med. 191, 445–454 (2000).
Amariglio, E.N. et al. Identity of rearranged LINE/c-MYC junction sequences specific for the canine transmissible venereal tumor. Proc. Natl. Acad. Sci. USA 88, 8136–8139 (1991).
Kedes, D.H. et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat. Med. 2, 918–924 (1996).
Gao, S.J. et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat. Med. 2, 925–928 (1996).
Farge, D. et al. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d'Ile de France (GCIF). Transplantation 67, 1236–1242 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moore, P. Transplanting cancer: donor-cell transmission of Kaposi sarcoma. Nat Med 9, 506–507 (2003). https://doi.org/10.1038/nm865
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm865
This article is cited by
-
Posttransplant lymphoproliferative disease: Pathogenesis, monitoring, and therapy
Current Oncology Reports (2003)